መነሻ › ክሮኒክ ማይሎሞኖሳይቲክ ሉኬሚያ › Texas › Houston
በHouston፣ TX ለክሮኒክ ማይሎሞኖሳይቲክ ሉኬሚያ የሚደረጉ ክሊኒካዊ ጥናቶች
ለክሮኒክ ማይሎሞኖሳይቲክ ሉኬሚያ የሚደረጉ 16 ጥናቶች በHouston እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
ተሳታዮችን በመፈለግ ላይደረጃ 2
- The University of Texas MD Anderson Cancer Center, Houston
Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation
ተሳታዮችን በመፈለግ ላይደረጃ 2
- M D Anderson Cancer Center, Houston
A Phase 2 Study Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Significance and Lower-risk Myelodysplastic/Syndromes/Chronic Myelomonocytic Leukemia.
ተሳታዮችን በመፈለግ ላይደረጃ 2ጤናማ ተሳታዮች ይቀበላሉ
- MD Anderson Cancer Center, Houston
Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
ተሳታዮችን በመፈለግ ላይደረጃ 2
- M D Anderson Cancer Center, Houston
Pacritinib vs. Hydroxyurea in Advanced Proliferative Chronic Myelomonocytic Leukemia
ተሳታዮችን በመፈለግ ላይደረጃ 2
- MD Anderson Cancer Center, Houston
Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS
ተሳታዮችን በመፈለግ ላይደረጃ 2/3ጤናማ ተሳታዮች ይቀበላሉ
- M D Anderson Cancer Center, Houston
Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- M D Anderson Cancer Center, Houston
Personalized NK Cell Therapy in CBT
ተሳታዮችን በመፈለግ ላይደረጃ 2
- M D Anderson Cancer Center, Houston
Phase I/II Clinical Trial of Axatilimab, a CSF1R Monoclonal Antibody, in Combination With Ruxolitinib as Therapy for Patients With Myelofibrosis (MF) and Chronic Myelomonocytic Leukemia (CMML)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- The University of Texas M. D. Anderson Cancer Center, Houston
A Phase II, Open-Label, Study of Subcutaneous Canakinumab, an Anti-IL-1β Human Monoclonal Antibody, for Patients With Low or Int-1 Risk IPSS/IPSS-R Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia
ተሳታዮችን በመፈለግ ላይደረጃ 2
- M D Anderson Cancer Center, Houston
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
ተሳታዮችን በመፈለግ ላይደረጃ 1
- M D Anderson Cancer Center, Houston
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
- MD Anderson Cancer Center, Houston
Azacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative Neoplasm
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- M D Anderson Cancer Center, Houston
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
ተሳታዮችን በመፈለግ ላይደረጃ 2
- MD Anderson, Houston
A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
ተሳታዮችን በመፈለግ ላይደረጃ 1
- MD Anderson Cancer Center, Houston
A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)
ተሳታዮችን በመፈለግ ላይደረጃ 1
- MD Anderson Cancer Center, Houston
በሌሎች ከተሞች ለክሮኒክ ማይሎሞኖሳይቲክ ሉኬሚያ የሚደረጉ ጥናቶች
- Seattle, WA10 ጥናቶች
- Boston, MA7 ጥናቶች
- Mountain View, CA6 ጥናቶች
- Baldwin Park, CA6 ጥናቶች
- Rochester, MN6 ጥናቶች
- New York City, NY6 ጥናቶች
- Durham, NC5 ጥናቶች
- Miami, FL4 ጥናቶች
- Tampa, FL4 ጥናቶች
- Birmingham, AL4 ጥናቶች
- Columbus, OH4 ጥናቶች
- Atlanta, GA4 ጥናቶች
በHouston ውስጥ ያሉ ሌሎች ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር145 ጥናቶች
- የጡንቻ ካንሰር126 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)121 ጥናቶች
- Metastatic Cancer104 ጥናቶች
- የኮሎሬክታል ካንሰር102 ጥናቶች
- የእንቁላል ካንሰር89 ጥናቶች
- አኩት ማይሎይድ ሊውኬሚያ85 ጥናቶች
- የሳንባ ካንሰር78 ጥናቶች
- የፕሮስቴት ካንሰር76 ጥናቶች
- የኤንዶሜትሪየም ካንሰር68 ጥናቶች
- የፓንክሪያስ ካንሰር61 ጥናቶች
- ሜላኖማ59 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።